This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Gerolymatos International S.a., Apim Therapeutics as. Active years: 2019-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2026
Title: Innovations by Konstantinos Alevizopoulos in Respiratory Treatments
Introduction
Konstantinos Alevizopoulos is an accomplished inventor based in Yverdon-les-Bains, Switzerland. He has made significant contributions to the field of respiratory health through his innovative patents. With a focus on developing effective treatments for respiratory conditions, Alevizopoulos has garnered attention for his unique approaches.
Latest Patents
Alevizopoulos holds 3 patents that focus on methods for treating respiratory conditions using ionic aqueous polysaccharide compositions. His latest patents disclose ionic aqueous compositions that are useful as nasal passage washes. These compositions aid in the resorption of edema of the respiratory mucosa, specifically targeting conditions such as chronic rhinosinusitis, sinusitis, allergic rhinitis, and nasal polyps. The compositions include an ionic aqueous solution and algae-derived constituents, such as branched, sulfated polysaccharides with specific molecular weight and chemical properties. Additionally, the patents outline methods and pharmaceutical compositions for treating respiratory tract and mucosal-related conditions.
Career Highlights
Alevizopoulos is associated with Gerolymatos International S.A., where he continues to develop and refine his innovative solutions for respiratory health. His work is characterized by a commitment to improving patient outcomes through scientific research and practical applications.
Conclusion
Konstantinos Alevizopoulos is a notable inventor whose work in respiratory treatments showcases the potential of innovative approaches in healthcare. His contributions are paving the way for advancements in the treatment of respiratory conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile